
OrbiMed targets $750m for Asia healthcare fund
US-based healthcare investment firm OrbiMed has launched its fourth Asian private equity fund with a view to raising $750 million.
The target, confirmed in a regulatory filing, represents an incremental step up versus the firm’s third fund, which closed at $551 million in 2017. That vehicle focused on growth-stage companies in China and India, with about 20% allocated to early-stage drug developers. OrbiMed typically deploys in a $10-75 million range.
The launch coincides with the promotion of David Bonita to general partner at the firm. Bonita’s investment experience includes a number of biopharmaceutical and medical device companies. He will serve alongside six existing general partners.
“David’s investments have contributed significantly to the financial returns enjoyed by OrbiMed’s clients, but more importantly his companies have discovered and developed numerous therapies that treat life-threatening unmet medical needs,” Jonathan Silverstein, another partner, said in statement.
OrbiMed invests globally across strategies including private and public equities as well as credit via bases in the US, China, Hong Kong, India, and Israel. It has about $13 billion in assets under management, with standout portfolio companies including Vivimed Labs, a revenue-generating drug maker based in India that has raised at least $50 million.
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.